Doctor profile · Federal record
Dr. Christopher Kellogg, MD
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Chandler, AZ
- NPI 1740254457
- Accepts Medicare
- MIPS 93.6 / 100 · 2023
- 40 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
695 S Dobson RD
Chandler, AZ 852245665
(480) 821-2838
fax (480) 821-9444 - Mailing address
-
Po Box 6423
Chandler, AZ 852466423
Credentials & registration
- NPI registered
- February 2006 — 20 yrs on file
- Profile last updated
- November 15, 2022
- Year of graduation
- 1986 — 40 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Arizona #23612
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1740254457. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
21,279
Distinct HCPCS
10
Medicare allowed
$1,086,327
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J9271 |
Injection, pembrolizumab, 1 mg | 17,000 | 13 | $54 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 1,102 | 18 | $0 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 990 | 17 | $1 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 984 | 459 | $87 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 341 | 35 | $125 | |
96367 |
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 223 | 26 | $28 | |
96375 |
Injection of additional new drug or substance into vein | 121 | 19 | $15 | |
99441 |
Telephone medical discussion with physician, 5-10 minutes | 89 | 63 | $54 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 76 | 76 | $108 | |
96417 |
Administration of additional new drug or substance into vein, 1 hour or less | 71 | 12 | $62 |
In context: peer comparison
Among 5 peers in this city , average services per provider: 1,478. This provider delivers 14× the peer median.Open Payments
Industry payments received
All-time total
$703
Transactions
40
Manufacturers
13
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| PFIZER INC. | 14 | $222.41 | |
| Novartis Pharmaceuticals Corporation | 7 | $143.11 | |
| ABBVIE INC. | 3 | $67.65 | |
| Celgene Corporation | 4 | $67.58 | |
| Daiichi Sankyo Inc. | 2 | $54.11 | |
| AstraZeneca Pharmaceuticals LP | 1 | $22.39 | |
| Mirati Therapeutics, Inc. | 1 | $22.26 | |
| ARRAY BIOPHARMA INC | 3 | $21.93 | |
| Genentech USA, Inc. | 1 | $18.62 | |
| GlaxoSmithKline, LLC. | 1 | $16.76 | |
| Merck Sharp & Dohme LLC | 1 | $16.27 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $15.87 | |
| Janssen Biotech, Inc. | 1 | $14.13 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
704
Patients
135
Total drug cost
$118,717
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Letrozole | Generic | 129 | 34 | $4,183 |
| Acyclovir | Generic | 57 | 0 | $843 |
| Hydroxyurea | Generic | 51 | 13 | $2,580 |
| Eliquis (Apixaban) | Brand | 50 | 11 | $41,478 |
| Prednisone | Generic | 49 | 13 | $369 |
| Anagrelide Hcl | Generic | 44 | 0 | $10,499 |
| Imatinib Mesylate | Generic | 43 | 0 | $42,902 |
| Tamoxifen Citrate | Generic | 43 | 12 | $1,815 |
| Levothyroxine Sodium | Generic | 42 | 13 | $543 |
| Dexamethasone | Generic | 40 | 15 | $643 |
Frequently asked questions
What is Dr. Christopher Kellogg's medical specialty?
Dr. Christopher Kellogg practices Hematology & Oncology Physician in Chandler, AZ.
Where does Dr. Christopher Kellogg practice?
Dr. Christopher Kellogg practices at 695 S Dobson RD, Chandler, AZ 852245665. Office phone: 4808212838.
What is Dr. Christopher Kellogg's NPI?
Dr. Christopher Kellogg's National Provider Identifier (NPI) is 1740254457, issued by NPPES.
Does Dr. Christopher Kellogg accept Medicare assignment?
Yes. Dr. Christopher Kellogg accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Christopher Kellogg commonly perform?
Top Medicare-reported procedures in 2023: Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, dexamethasone sodium phosphate, 1 mg (HCPCS J1100); Injection, palonosetron hcl, 25 mcg (HCPCS J2469). Source: CMS Medicare Physician & Other Practitioners file.